By Associate Professor Suzanne Jean Hodgkinson

Journal articles

Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RA; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies JM; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2015, 'A new era in the treatment of multiple sclerosis', Medical Journal of Australia, 203, pp. 139 - 141, http://dx.doi.org/10.5694/mja14.01218

Mackay AM; Buckingham R; Schwartz RS; Hodgkinson S; Beran RG; Cordato DJ, 2015, 'The Effect of Biofeedback as a Psychological Intervention in Multiple Sclerosis: A Randomized Controlled Study', International Journal of MS Care, 17, pp. 141010081652001 - 141010081652001, http://dx.doi.org/10.7224/1537-2073.2014-006

Kister I; Spelman T; Duquette P; Girard M; Lechner-Scott J; Grand'Maison F; Slee M; Hodgkinson S; Lugaresi A; Edite Rio M; Trojano M; Butzkueven H; Herbert J, 2015, '‘Doctor, can I stop my medicine?’ Analysis of disease course after stopping disease-modifying therapy in stable MS patients (P5.192)', Neurology, 84, http://dx.doi.org/10.1212/wnl.84.14_supplement.p5.192

He A; Spelman T; Jokubaitis V; Havrdova E; Horakova D; Trojano M; Lugaresi A; Izquierdo G; Grammond P; Duquette P; Girard M; Pucci E; Iuliano G; Alroughani R; Oreja-Guevara C; Fernandez-Bolaños R; Grand'Maison F; Sola P; Spitaleri D; Granella F; Terzi M; Lechner-Scott J; Van Pesch V; Hupperts R; Sánchez-Menoyo JL; Hodgkinson S; Rozsa C; Verheul F; Butzkueven H; Kalincik T; Giuliani G; Cartechini E; Rio ME; Zwanikken C; Flechter S; Kasa K; Amato MP; Shaygannejad V; Bergamaschi R; Slee M; Boz C; Moore F; Barnett M; Vucic S; McCombe P; Cabrera-Gomez JA; Petersen T; Ramo C; Roullet E; Den Braber-Moerland L; Paolicelli D; Iaffaldano P; Direnzo V; D'Onghia M; Piroska I; Erdelyi T; Iljicsov A; Kovacs K; Sas A; Skibina O; Haartsen J; van Munster E; Fiol M; Correale J; Ysrraelit C; Herbert J; Kister I; Sirbu CA; Shaw C; Vetere S; Petkovska-Boskova T; Singhal B; Bacile EA; Arruda WO; Roger E; Despault P; Marriott M; Van der Walt A; King J; Byron J; Morgan L; Hinson E; De Luca G; Di Tommaso V; Travaglini D; Pietrolongo E; di Ioia M; Farina D; Mancinelli L; Rojas JI; Patrucco L; Williams D; Dark L; Savino A; Chapman J; Cristiano E; Saladino ML; Deri N; Gray O; Hughes S, 2015, 'Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis', JAMA Neurology, 72, pp. 405 - 413, http://dx.doi.org/10.1001/jamaneurol.2014.4147

Arguedas D; Stewart J; Hodgkinson S; Batchelor J, 2015, 'A neuropsychological comparison of siblings with neurological versus hepatic symptoms of Wilson’s Disease', Neurocase, 21, pp. 154 - 161, http://dx.doi.org/10.1080/13554794.2013.878726

Kalincik T; Horakova D; Spelman T; Jokubaitis V; Trojano M; Lugaresi A; Izquierdo G; Rozsa C; Grammond P; Alroughani R; Duquette P; Girard M; Pucci E; Lechner-Scott J; Slee M; Fernandez-Bolanos R; Grand'Maison F; Hupperts R; Verheul F; Hodgkinson S; Oreja-Guevara C; Spitaleri D; Barnett M; Terzi M; Bergamaschi R; McCombe P; Sanchez-Menoyo J; Simo M; Csepany T; Rum G; Boz C; Havrdova E; Butzkueven H, 2015, 'Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis', Annals of Neurology, 77, pp. 425 - 435, http://dx.doi.org/10.1002/ana.24339

Calic Z; Cappelen-Smith C; Hodgkinson SJ; McDougall A; Cuganesan R; Brew BJ, 2015, 'Treatment of progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with intravenous immunoglobulin in a patient with multiple sclerosis treated with fingolimod after discontinuation of natalizumab', Journal of Clinical Neuroscience, http://dx.doi.org/10.1016/j.jocn.2014.08.016

Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies', Journal of Clinical Neuroscience, 21, pp. 1835 - 1846, http://dx.doi.org/10.1016/j.jocn.2014.01.016

Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy', Journal of Clinical Neuroscience, 21, pp. 1847 - 1856, http://dx.doi.org/10.1016/j.jocn.2014.01.018

Broadley SA; Barnett MH; Boggild M; Brew BJ; Butzkueven H; Heard R; Hodgkinson S; Kermode AG; Lechner-Scott J; Macdonell RAL; Marriott M; Mason DF; Parratt J; Reddel SW; Shaw CP; Slee M; Spies J; Taylor BV; Carroll WM; Kilpatrick TJ; King J; McCombe PA; Pollard JD; Willoughby E, 2014, 'Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations', Journal of Clinical Neuroscience, 21, pp. 1857 - 1865, http://dx.doi.org/10.1016/j.jocn.2014.01.017

Jokubaitis VG; Li V; Kalincik T; Izquierdo G; Hodgkinson S; Alroughani R; Lechner-Scott J; Lugaresi A; Duquette P; Girard M; Barnett M; Grand'Maison F; Trojano M; Slee M; Giuliani G; Shaw C; Boz C; Spitaleri DLA; Verheul F; Haartsen J; Liew D; Butzkueven H, 2014, 'Fingolimod after natalizumab and the risk of short-term relapse', Neurology, 82, pp. 1204 - 1211, http://dx.doi.org/10.1212/WNL.0000000000000283

Rege S; Hodgkinson SJ, 2014, 'Anti-neuronal antibodies associated with a first episode of mania', Australian and New Zealand Journal of Psychiatry, 48, pp. 775 - 777, http://dx.doi.org/10.1177/0004867414536934

Verma ND; Hall BM; Plain KM; Robinson CM; Boyd R; Tran GT; Wang C; Bishop GA; Hodgkinson SJ; Verma N, 2014, 'Interleukin-12 (IL-12p70) promotes induction of highly potent Th1-like CD4⁺CD25⁺ T regulatory cells that inhibit allograft rejection in unmodified recipients', Frontiers in Immunology, 5, pp. 190, http://dx.doi.org/10.3389/fimmu.2014.00190

Rege S; Hodgkinson SJ, 2013, 'Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application', Australian and New Zealand Journal of Psychiatry, 47, pp. 1136 - 1151, http://dx.doi.org/10.1177/0004867413499077

Hall BM; Tran GT; Verma ND; Plain KM; Robinson CM; Nomura M; Hodgkinson SJ, 2013, 'Do natural T regulatory cells become activated to antigen specific T regulatory cells in transplantation and in autoimmunity?', Frontiers in Immunology, 4, http://dx.doi.org/10.3389/fimmu.2013.00208

Plain KM; Verma ND; Tran GT; Nomura M; Boyd R; Robinson CM; Hodgkinson SJ; Hall BM, 2013, 'Cytokines affecting CD4⁺ T regulatory cells in transplant tolerance. Interleukin-4 does not maintain alloantigen specific CD4⁺CD25⁺ Treg', Transplant Immunology, 29, pp. 51 - 59, http://dx.doi.org/10.1016/j.trim.2013.10.003

Cordato DJ; Djekic ; Taneja SR; Maley M; Beran RG; Cappelen-Smith C; Griffith N; Hanna IY; Hodgkinson SJ; Worthington JM; Mcdougall AJ, 2013, 'Prevalence of positive syphilis serology and meningovascular neurosyphilis in patients admitted with stroke and TIA from a culturally diverse population (2005–09)', Journal of Clinical Neuroscience, 20, pp. 943 - 947, http://dx.doi.org/10.1016/j.jocn.2012.08.011

Tran GT; Hodgkinson SJ; Carter N; Verma ND; Plain KM; Boyd RA; Robinson C; Nomura M; Killingsworth MC; Hall BM, 2012, 'IL-5 promotes induction of antigen-specific CD4 +CD25 + T regulatory cells that suppress autoimmunity', Blood, 119, pp. 4441 - 4450, http://dx.doi.org/10.1182/blood-2011-12-396101

Ghia D; Thomas PC; Cordato DJ; Epstein D; Beran RG; Cappelen-Smith C; Griffith N; Hanna I; Mcdougall AJ; Hodgkinson SJ; Worthington JM, 2012, 'Low positive predictive value of the ABCD2 score in Emergency Department TIA diagnoses - South West Sydney (SWS) TIA Study', Internal Medicine Journal, 42, pp. 913 - 918, http://dx.doi.org/10.1111/j.1445-5994.2011.02564.x

Lu B; Roussel JC; Murray-Segal L; Salvaris E; Hodgkinson SJ; Hall BM; D'apice AJFF; Cowan P; Gock H, 2012, 'Protective effects of transgenic human endothelial protein C receptor expression in murine models of transplantation', American Journal of Transplantation, 12, pp. 2363 - 2372, http://dx.doi.org/10.1111/j.1600-6143.2012.04122.x

Tran T; Hodgkinson S; Carter N; Verma N; Plain K; Nomura M; Robinson C; Killingsworth M; Boyd R; Hall B, 2011, 'Antigen specific CD4+CD25+Tregs promoted by IL-5 and IL-4 prevented demyelination', MULTIPLE SCLEROSIS JOURNAL, 17, pp. S430 - S430, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209137301318&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Tran G; Hodgkinson S; Carter N; Verma N; Robinson C; Plain K; Boyd R; Hall B, 2011, 'Induction of antigen specific CD4+CD25+T regulatory cells in vitro that control demyelination in autoimmune disease', MULTIPLE SCLEROSIS JOURNAL, 17, pp. S205 - S205, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000209137300412&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hall BM; Verma ND; Tran GT; Hodgkinson SJ, 2011, 'Distinct regulatory CD4+T cell subsets; differences between naı ̈ve and antigen specific T regulatory cells', Current Opinion in Immunology, 23, pp. 641 - 647, http://dx.doi.org/10.1016/j.coi.2011.07.012

Wang C; Szun szun T; Tran GT; Hodgkinson SJ; Allen R; Hall BM; Mccaughan GW; Sharland A; Bishop A, 2010, 'Donor IL-4-treatment induces alternatively activated liver macrophages and IDO-expressing NK cells and promotes rat liver allograft acceptance', Transplant Immunology, 22, pp. 172 - 178, http://dx.doi.org/10.1016/j.trim.2009.11.005

Tran GT; Hodgkinson SJ; Carter N; Killingsworth MC; Nomura M; Verma ND; Plain KM; Boyd RA; Hall BM, 2010, 'Membrane attack complex of complement is not essential for immune mediated demyelination in experimental autoimmune neuritis', Journal of Neuroimmunology, 229, pp. 98 - 106, http://dx.doi.org/10.1016/j.jneuroim.2010.07.010

Ghia D; Thomas P; Cordato DJ; Worthington JM; Cappelen-Smith C; Griffith N; Hanna IY; Hodgkinson SJ; Mcdougall AJ; Beran RG, 2010, 'Validation of Emergency and Final Diagnosis Coding in Transient Ischemic Attack: South Western Sydney Transient Ischemic Attack Study', Neuroepidemiology, 35, pp. 53 - 58, http://dx.doi.org/10.1159/000310338

Brown RF; Valpiani EM; Tennant CC; Dunn SM; Sharrock M; Hodgkinson S; Pollard JD, 2009, 'Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis', Psychology and Psychotherapy: Theory, Research and Practice, 82, pp. 41 - 56, http://dx.doi.org/10.1348/147608308X345614

Hall BM; Tran GT; Hodgkinson SJ, 2009, 'Alloantigen specific T regulatory cells in transplant tolerance', International Immunopharmacology, 9, pp. 570 - 574

Verma ND; Plain KM; Nomura M; Tran GT; Boyd RA; Hodgkinson SJ; Hall BM; Robinson C, 2009, 'CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses', Blood, 113, pp. 479 - 487

Cordato DJ; Thomas PC; Ghia D; Taneja S; Worthington JM; Mcdougall AJ; Hodgkinson SJ; Hanna IY; Griffith N; Cappelen-Smith C; Beran RG, 2009, 'Decreasing presentations of seizures to emergency departments in a large Australian population', Epilepsy and Behavior, 16, pp. 475 - 478, http://dx.doi.org/10.1016/j.yebeh.2009.08.027

Verma ND; Plain KM; Nomura M; Tran GT; Boyd R; Carter N; Robinson C; Wang C; Bishop GA; Hodgkinson SJ; Hall BM, 2008, '+CD25+FOXP3+T ALLOANTIGEN ACTIVATED NAIVE CD4 REGULATORY CELLS EXPRESS CD8; A MARKER OF NEWLY ACTIVATED ANTIGEN SPECIFIC T REGULATORY CELLS', Transplantation, 86, pp. 486 - 486, http://dx.doi.org/10.1097/01.tp.0000331421.48421.97

Hall B; Plain K; Nomura M; Verma N; Tran G; Boyd R; Robinson C; Hodgkinson S, 2008, 'ALLOGRAFT TOLERANCE MEDIATING CD4+T CELLS DEPEND UPON INTERLEUKIN-5 (IL-5), NOT IL-4.', Transplantation, 86, pp. 136 - 136, http://dx.doi.org/10.1097/01.tp.0000332495.28926.ce

Verma ND; Plain KM; Nomura M; Robinson C; Tran GT; Boyd R; Hodgkinson SJ; Hall BM, 2008, 'ANTIGEN SPECIFIC T REGULATORY CELLS FROM TOLERANT HOSTS EXHIBIT PHENOTYPES SIMILAR TO CELLS THAT WERE ACTIVATED IN VITRO AND USED TO INDUCE TOLERANCE', Transplantation, 86, pp. 486 - 486, http://dx.doi.org/10.1097/01.tp.0000331422.56045.85

Plain K; Verma N; Robinson C; Tran G; Boyd R; Hodgkinson S; Hall B, 2008, 'IL-4 HAS TOLEROGENIC AND ALLOGENIC EFFECTS: IT ACTIVATES CD4+CD25+ T CELLS TO INDUCE SPECIFIC TRANSPLANT TOLERANCE AND PROMOTES REJECTION, EFFECTING CD4+CD25-T CELLS TO EXPRESS CD25 BUT NOT FOXP3.', Transplantation, 86, pp. 513 - 514, http://dx.doi.org/10.1097/01.tp.0000331185.87776.58

Lam V; Taylor CF; Laurence JM; Wang C; Sharland A; McCaughan G; Hodgkinson SJ; Allen R; Hall BM; Bishop A, 2008, 'Heart allograft acceptance induced by anti-CD3 antibody in high-responder rats: Effect on foxp3 and cytokine expression and graft infiltration', Transplant Immunology, 19, pp. 20 - 24, http://dx.doi.org/10.1016/j.trim.2008.01.002

Kehdi E; Cordato DJ; Thomas P; Beran RG; Cappelen-Smith C; Griffith N; Hanna I; Mcdougall AJ; Worthington JM; Hodgkinson SJ, 2008, 'Outcomes of patients with transient ischaemic attack after hospital admission or discharge from the emergency department', Medical Journal of Australia, 189, pp. 9 - 12

Hall BM; Robinson C; Plain KM; Verma ND; Carter N; Boyd RA; Tran GT; Hodgkinson SJ, 2008, 'Studies on naive CD4(+) CD25(+) T cells inhibition of naive CD4(+) CD25(-)T cells in mixed lymphocyte cultures', Transplant Immunology, 18, pp. 291 - 301, http://dx.doi.org/10.1016/j.trim.2007.09.002

Richards A; Van Den Maagdenberg AMJM; Jen JC; Kavanagh D; Bertram P; Spitzer D; Liszewski MK; Barilla-Labarca ML; Terwindt GM; Kasai Y; McLellan M; Grand MG; Vanmolkot KRJ; De Vries B; Wan J; Kane MJ; Mamsa H; Schäfer R; Stam AH; Haan J; De Jong PTVM; Storimans CW; Van Schooneveld MJ; Oosterhuis JA; Gschwendter A; Dichgans M; Kotschet KE; Hodgkinson S; Hardy TA; Delatycki MB; Hajj-Ali RA; Kothari PH; Nelson SF; Frants RR; Baloh RW; Ferrari MD; Atkinson JP, 2007, 'C-terminal truncations in human 3′-5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy', Nature Genetics, 39, pp. 1068 - 1070, http://dx.doi.org/10.1038/ng2082

Hodgkinson SJ; Sedal L; Paine M; Seijka S; Butzkueven H; Booth D; Mackay F; Tabensky A, 2007, '317: Developing strategies to manage neutralising antibodies – preliminary results from the RENeu study and some individual case reports', Journal of Clinical Neuroscience, 14, pp. 1013 - 1014, http://dx.doi.org/10.1016/j.jocn.2007.02.023

Davidson C; Verma ND; Robinson C; Plain KM; Tran GT; Hodgkinson SJ; Hall BM, 2007, 'IL-13 prolongs allograft survival: Association with inhibition of macrophage cytokine activation', Transplant Immunology, 17, pp. 178 - 186

Spicer ST; Tran GT; Killingsworth MC; Carter N; Power D; Paizis K; Boyd RA; Hodgkinson SJ; Hall BM, 2007, 'Induction of passive Heymann nephritis in complement component 6-deficient PVG rats', Journal of Immunology, 179, pp. 172 - 178

Hall BM; Plain KM; Verma ND; Tran GT; Boyd RA; Robinson C; Nicolls M; Berger M; Nomura M; Hodgkinson SJ, 2007, 'Transfer of allograft specific tolerance requires CD4(+)CD25(+)T cells but not interleukin-4 or transforming growth factor-beta and cannot induce tolerance to linked antigens', Transplantation, 83, pp. 1075 - 1084

Plain KM; Boyd RA; Verma ND; Robinson C; Tran GT; Hodgkinson SJ; Hall BM, 2007, 'Transplant tolerance associated with a Th1 response and not broken by IL-4, IL-5, and TGF-beta blockade or Th1 cytokine administration', Transplantation, 83, pp. 764 - 773

Hodgkinson SJ; Sedal L; Paine M; Siejka S; Gorai D; Butzkueven H; Willoughby E; Boundy KL; Booth D; Mackay F; Tabensky A; Sartori L; Curnow K, 2006, 'Developing strategies to manage neutralising antibodies - preliminary results from the RENeu study', Multiple Sclerosis, 12, pp. S203 - S204

Brown RF; Tennant CC; Sharrock M; Hodgkinson SJ; Dunn SM; Pollard JD, 2006, 'Relationship between stress and relapse in multiple sclerosis: part II Direct and indirect relationships.', Multiple Sclerosis, 12, pp. 465 - 475

Brown RF; Tennant CC; Sharrock M; Hodgkinson SJ; Dunn SM; Pollard JD, 2006, 'Relationship between stress and relapse in multiple sclerosis:Part 1. Important features', Multiple Sclerosis, 12, pp. 453 - 464

Nomura M; Plain KM; Verma ND; Robinson C; Boyd RA; Hodgkinson SJ; Hall BM, 2006, 'The cellular basis of cardiac allograft rejection. IX. Ratio of naïve CD4+CD25+ T cells / CD4+CD25− T cells determines rejection or tolerance', Transplant Immunology, 15, pp. 311 - 318

Wang C; Li J; Cordoba S; McLeod D; Tran GT; Hodgkinson SJ; Hall BM; Mccaughan GW; Bishop G, 2005, 'Posttransplant interleukin-4 treatment converts rat liver allograft tolerance to rejection', Transplantation, 79, pp. 1116 - 1120

Levi CR; Blacker DJ; Bladin CF; Boers PM; Chambers BR; Chu LL; Corbett AJ; Crimmins DS; Davis SM; Donnan GA; Dunbabin DW; Fink JN; Frayne JH; Gerraty RP; Hankey GJ; Hodgkinson SJ; Hughes JT; Ingall TJ; Landau PB; Lindley RI; Long PW; Markus R; Mullins EM; Parsons MW; Pollack MRP; Read SJ; Rosen DM; Schultz DW; Serisier DE; Watson JDG; Storey CE; Zagami AA, 2004, 'Tissue plasminogen activator (tPA) in acute ischaemic stroke: Time for collegiate communication and consensus', Medical Journal of Australia, 180, pp. 634 - 636, http://dx.doi.org/10.5694/j.1326-5377.2004.tb06127.x

Bishop GA; Li J; Trang G; Hodgkinson SJ; Hall BM; McCaughan GW; Allen RDM; Wang C, 2004, 'POST-TRANSPLANT IL-4 TREATMENT CONVERTS RAT LIVER ALLOGRAFT TOLERANCE TO REJECTION', Transplantation, 78, pp. 153 - 153, http://dx.doi.org/10.1097/00007890-200407271-00404

Back to profile page